It is needless to mention that the tug-of-war between cancer and researchers has been growing stronger and stronger. On one side, cancer has positioned itself as…
Month: November 2018
Nov 29 
The Business Cocktail
Prometic bags USD 50 Million stock sale option to ease a cash crunch Prometic Life Sciences got into an agreement for selling USD 50 million in stock. This…
Nov 28 
Researchers say CRISPR edits to a human embryo worked
The researchers announced that they had edited human embryos to repair a damaged gene that can lead to heart failure, but critics raised their eyebrows. Now,…
Nov 26 
Sleeping at Workplaces: Re-energizing Formula or OSA Disease?
Do you often sleep during work? Well, if you do so, you might proudly claim yourself to be an efficient and hard worker as work stress…
Nov 23 
Will Technology Eventually Render Chemotherapy as Redundant for Cancer Treatment?
It is needless to mention that Chemotherapy has been the most dependable cancer therapy. But, a new area of research shows the possibility of technology taking…
Nov 22 
The Business Cocktail
Cambrex takes over Avista in USD 250 Million agreement Cambrex, life sciences company, is taking over Avista Pharma Solutions with a deal of USD 250 million to become…
Nov 21 ![Newsletter]( "Newsletter")
Nov 21 
Snippet- The lab-grown mini brains generate electrical patterns
The Mini brains grown in a dish have produced human-like brain waves. They are the electrical patterns look similar to those of premature babies. This would…
Nov 16 
Actinic Keratosis – A Warning Sign for Potential Skin Cancer
Actinic keratosis (AK) is a chronic and prevalent disease affecting areas of sun-exposed skin where visible and subclinical, non-visible lesions coexist. AK lesions are being represented…
